EUCTR2009-015100-25-FR进行中（未招募）不适用
Cohorte multicentrique nationale de patients atteints de grippe pandémique(nouveau virus A/H1N1v d’origine porcine) - Etude Flu Co
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- INSERM
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Eligibilité : diagnostic clinique d’un syndrome grippal (cas possibles définis par l’INVS), consentement signé
- •Inclusion : diagnostic de grippe A/H1N1v confirmé par RT-PCR
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Non applicable
研究者
相似试验
进行中（未招募）
1 期
ENSAYO CLÍNICO MULTICÉNTRICO, MULTINACIONAL, ABIERTO, ALEATORIZADO, CON GRUPOS PARALELOS DE TOBRINEB®/ACTITOB®/ BRAMITOB® (TOBRAMICINA SOLUCIÓN PARA NEBULIZACIÓN, 300 mg DOS VECES AL DÍA EN VIALES UNIDOSIS DE 4 ML) EN COMPARACIÓN CON TOBI® EN EL TRATAMIENTO DE PACIENTES CON FIBROSIS QUÍSTICA E INFECCIÓN CRÓNICA POR PSEUDOMONAS AERUGINOSAEUCTR2006-006215-68-ESChiesi Farmaceutici S.p.A324
进行中（未招募）
不适用
Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseEUCTR2005-002088-98-ATAmarin Neuroscience Ltd240
进行中（未招募）
不适用
Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseHUNTINGTON’S DISEASEMedDRA version: 8.0Level: LLTClassification code 10010331EUCTR2005-002088-98-PTAmarin Neuroscience Ltd
进行中（未招募）
不适用
Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseHUNTINGTON’S DISEASEMedDRA version: 8.0Level: LLTClassification code 10010331EUCTR2005-002088-98-GBAmarin Neuroscience Ltd
进行中（未招募）
不适用
Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseEUCTR2005-002088-98-DEAmarin Neuroscience Ltd240